Neuropsychiatry or biological psychiatry;Neuropsychiatrie of biologische psychiatrie; een toekomstvisie in historisch perspectief

Acta Neuropsychiatrica

Volumn 11, Issue 2, 1999, Pages 80-84

  Verhoeven, W M A ^a,b   Tuinier, S ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

Author keywords

Biological psychiatry; Motivational deficit disorder; Neuronal circuits; Neuropsychiatry

Indexed keywords

BEHAVIOR DISORDER; MEDICAL RESEARCH; MOTIVATION; NERVE CELL NETWORK; NEUROPSYCHIATRY; REVIEW;

EID: 0033064365     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0924270800036231     Document Type: Review

References (56)

1. Trimble MR. Neuropsychiatry or behavioral neurology. Neuropsychiat, Neuropsychol Behav Neurol 1993; 6: 60-9.
2. Godderis J. Galenos van Pergamon over psychische stoornissen: een bijdrage tot de geschiedenis van de begripsontwikkeling in de psychiatrie. Leuven/Amersfoort: Acco, 1988.
3. Von Bingen H. Ursachen und Behandlung der Krankheiten. München: Hugo Schulz, 1933.
4. Diethelm O. Medical Dissertations of psychiatric Interest: printed before 1750. Basel: Karger, 1971.
5. Neugebauer R. Treatment of the mentally ill in medieval and early modern England: a reappraisal. J Hist behav Sci 1978; 14: 158-69.
6. Trevisa J. On the Properties of Things. Oxford: Clarendon Press, 1998.
7. Manzoni T. The cerebral ventricles, the animal spirits and the dawn of brain localization of function. Arch Ital Biol 1998; 136: 103-52.
8. Hill D. The bridge between neurology and psychiatry. Lancet 1964-I; 18: 509-14.
9. Lishman WA. Neurologists and psychiatrists. In: The bridge between neurology and psychiatry. Reynolds EH, Trimble MR, eds. Edinburgh: Churchill Livingstone 1989; 24-37.
10. Benson DF. Neuropsychiatry and behavioural neurology: past, present, and future. J Neuropsychiat 1996; 8: 351-7.
11. Verhey FHM. Acta Neuropsychiatrica; Tijdschrift voor een hedendaagse neuropsychiatrie. Acta Neuropsychiat 1989; 1: 3-8.
12. Schroeder van der Kolk JLC. Handboek van de pathologie en therapie der krankzinnigheid. Utrecht: FA Hartsen, 1863.
13. Magnan V. Leçons cliniques, 2nd edn. Paris: Bataille 1893.
14. Tuinier S. 'Gaslighting'. De opkomst van de psychofarmaca en de anti-psychiatrie. In: Geschiedenis, Psychologie, Mentaliteit. Damen M, Koedijk P, Pols F van der, Tellegen JW, Veltman E, eds. Amsterdam, Skript 1982; 77-100.
15. Praag HM van. 'Make-believes' in psychiatry or the perils of progress. New York: Bunner/Mazel, 1993.
16. Praag HM van. Voorbij de hoofdstroom: over de wetenschappelijke ankerpunten van een psychiatrische loopbaan. Amsterdam: Balans 1998.
17. Grawe K. Psychotherapieforschung zu Beginn der neunziger Jahre. Psychologische Rundschau 1992; 43: 132-62.
18. Bertolote JM, De Girolama G. Essential Treatment in Psychiatry, Geneve: WHO 1993.
19. Kadera SW, Lambert MJ, Andrews AA. How much therapy is really enough? J Psychother Pract Res 1996; 5: 132-51.
20. Cummings JL, Hegarty A. Neurology, psychiatry and neuropsychiatry. Neurology 1994; 44: 209-18.
21. Laborit J. Huguenard P, Alluaume R. Un nouveau stabilisateur végétatif (le 4560 RF). Press Med 1952; 60: 206-8.
22. Snyder SH, Banerjee SP, Yamamura HI, Greenberg D. Drugs, neurotransmitters, and schizophrenia. Science 1974; 184: 1243-53.
23. Verhoeven WMA. Neuropeptides and schizophrenia: a review and critical reappraisal. In: Advances in the Neurobiology of Schizophrenia. Boer JA den, Westenberg HGM, Praag HM van eds. Chichester; John Wiley and Sons, 1995: 303-26.
24. Fekkes D, Pepplinkhuizen L. Amino acid studies in transient acute polymorphic psychosis. Amino Acids 1997; 12: 107-17.
25. Kahn RS, Praag HM van. De rol van serotonine bij schizofrenie. In: Leerboek schizofrenie. Een neurobiologische benadering. J.A. den Boer en R.J. van den Bosch (Eds.). De Tijdstroom Utrecht 1996; 143-50.
26. Westenberg HGM, Den Boer JA. De neurochemische basis voor psychofarmaca; Over dopamine, serotonine, cholecystekinine en glutamaat. In: Leerboek schizofrenie. Een neurobiologische benadering. Boer JA den, Bosch RJ van den, eds. Utrecht: De Tijdstroom, 1996; 109-27.
27. Kuhn R. Uber die Behandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22355). Schweiz Med Wochenschr 1957; 35/36: 1135-40.
28. Praag HM van. Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression). Psychiat Res 1996; 65: 143-57.
29. Verhoeven WMA, Tuinier S. Neurotransmitters, hormonen en depressies; theorieën over de pathogenese. In: Handboek Stemmingsstoornissen. Boer JA den, Ormel J, Praag HM van, Westenberg HGM, D'haenen H, eds. Utrecht: De Tijdstroom, 1999; in press.
30. Parnham MJ, Bruinvels J. Discoveries in pharmacology, Volume I. Psycho- and Neuro-pharmacology. Amsterdam-New York: Elsevier, 1983.
31. Praag HM van, Asnis GM, Kahn RS, et al. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology, Ann N Y Acad Sci 1990; 600: 501-10.
32. Praag HM van, Leijnse B. Neubewerting des Syndroms. Skizze einer funktionellen Pathologie. Psychiat neurol Neurochir 1965; 8: 50-66.
33. Praag HM van, Asnis GM, Brown SL, et al. Beyond serotonin. A multi-aminergic perspective on abnormal behavior. In: Brown SL, Praag HM van, eds. The role of serotonin in psychiatry disorders. New York: Brunner/Mazel, 1991: 302-32.
34. Tuinier S, Verhoeven WMA. Neurobiologie van agressie en impulsiviteit. Acta Neuropsychiat 1999; 11: 5-10.
35. Verhoeven WMA, Tuinier S. Symptomatology and Pathophysiology of Psychotic Disorders in Parkinson's Disease. Eur J Psychiat 1995; 46: 9-37.
36. Stuiver BT, Sebens JB, Horst GJ ter, Korf J. Huidige inzichten in werkingsmechanismen van psychofarmaca. Pharm Weekbl 1994; 129: 511-6.
37. Northoff G. Ansätze zu einer Neuropsychiatrie als Uberbrückung der Trennung von Neurologie und Psychiatrie. Schweiz Arch Neurol Psychiatr 1992; 143: 27-38.
38. Cummings JL. Frontal subcortical circuits and human behaviour. Arch Neurol 1993; 50: 873-80.
39. Weitzner MA. Neuropsychiatry and pituitary disease: An overview. Psychother Psychosom 1998; 67: 125-32.
40. Kloet ER de. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991; 12: 95-164.
41. Kloet ER de. Neurobiologie van adaptatiestoornissen. Acta Neuropsychiat 1999; 11: 11-4.
42. Leshner AI. Addicton is a brain disease, and it matters. Science 1997; 278: 45-7.
43. Saint-Cyr JA, Taylor AE, Nicholson K. Behaviour and the basal ganglia. Adv Neurol 1995; 65: 1-28.
44. Verhoeven WMA, Tuinier S, Berg YWMM van den, Coppus, et al. Stress and self-injurious behaviour; hormonal and serotonergic parameters in mentally retarded subjects. Pharmacopsychiat 1999; 32: 13-20.
45. Verhoeven WMA, Tuinier S. Neuropsychiatriche diagnostiek. In: Verhoeven WMA, Tuinier S, Curfs LMG, eds. Diagnostiek en behandeling van gedragsproblemen bij verstandelijk gehandicapten. Cure & Care Development, 1999; in press.
46. Marin RS. Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991; 3: 243-54.
47. Marin RS, Fogel BS, Hawkins J, Duffey J, Krupp B. Apathy: A treatable syndrome. J Neuropsychiat clin Neurosci 1995; 7: 23-30.
48. Müller U, Von Cramon Y. The therapeutic potential of bromocriptine in neuropsychological rehabilitation of patiens with acquired brain damage. Prog Neuropsychopharmacol Biol Psychiat 1994; 18: 1103-20.
49. Cummings JL. Motility, behaviour and the brain. J psychosom Res 1998; 44: 643-44.
50. Sandman CA, Hetrick W, Taylor DV, Chicz-DeMet A. Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers. Am J ment Retard 1997; 102: 182-99.
51. Tuinier S, Verhoeven WMA. Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis. Eur Neuropsychopharmacol 1995; 5: 135-46.
52. Kandel ER. A new intellectual framework for psychiatry. Am J Psychiatry 1998; 155: 457-69.
53. Coffey CD, Cummings JL, Duffy JD, et al. Assessment of treatment outcomes in neuropsychiatry: A report from the committee on research of the American Neuropsychiatric Association. J Neuropsychiatr clin Neurosci 1995; 7: 287-9.
54. Cummings JL, Coffey CE, Duffy JD, et al. The clinician-scientist in neuropsychiatry: A position statement from the committee on research of the American Neuropsychiatric Association. J Neuropsychiat clin Neurosci 1998; 10: 1-9.
55. Ministerie van Volksgezondheid, Welzijn en Sport. Beleidsvisie Geestelijke Gezondheidszorg 1999. 's-Gravenhage: Ministerie van VWS, 1998.
56. Verhoeven WMA, Goessens LFM, Berg YWMM van den, Tuinier S. Integratie van opleiding en onderzoek in de opleiding tot psychiater. Acta Neuropsychiat 1999; 11: 18-23.